http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 17 Jun 2026 16:28:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26660314.html si-local-file:///var/storage/secattach/20260617/26660314.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26660314.html Wed, 17 Jun 2026 16:28:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26660314.html si-local-file:///var/storage/secattach/20260617/26660314.html http://www.streetinsider.com/SEC+Filings/Form++144++++++++TANDEM+DIABETES+CARE+++++++++++++++++++Filed+by%3A+Novara+Mark+David/26660314.html Wed, 17 Jun 2026 16:28:00 -0400 O.06012263 TNDM http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) received CE mark approval to expand use of its automated insulin delivery systems in Europe for people with type 1 diabetes during pregnancy and adults with type 2 diabetes.</p> <p>The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ technology can now be used by these patient populations in European markets where the devices are available.</p> <p>The pregnancy indication stems from results of the CIRCUIT trial published in the Journal of the American Medical Association in October 2025. The multi-center, randomized controlled trial found participants using the t:slim X2 insulin pump with Control-IQ technology experienced http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html Fri, 05 Jun 2026 08:30:20 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) received CE mark approval to expand use of its automated insulin delivery systems in Europe for people with type 1 diabetes during pregnancy and adults with type 2 diabetes.</p> <p>The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ technology can now be used by these patient populations in European markets where the devices are available.</p> <p>The pregnancy indication stems from results of the CIRCUIT trial published in the Journal of the American Medical Association in October 2025. The multi-center, randomized controlled trial found participants using the t:slim X2 insulin pump with Control-IQ technology experienced http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html Fri, 05 Jun 2026 08:30:20 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) received CE mark approval to expand use of its automated insulin delivery systems in Europe for people with type 1 diabetes during pregnancy and adults with type 2 diabetes.</p> <p>The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ technology can now be used by these patient populations in European markets where the devices are available.</p> <p>The pregnancy indication stems from results of the CIRCUIT trial published in the Journal of the American Medical Association in October 2025. The multi-center, randomized controlled trial found participants using the t:slim X2 insulin pump with Control-IQ technology experienced http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html Fri, 05 Jun 2026 08:30:20 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html <p>Tandem Diabetes Care Inc. (NASDAQ: TNDM) received CE mark approval to expand use of its automated insulin delivery systems in Europe for people with type 1 diabetes during pregnancy and adults with type 2 diabetes.</p> <p>The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ technology can now be used by these patient populations in European markets where the devices are available.</p> <p>The pregnancy indication stems from results of the CIRCUIT trial published in the Journal of the American Medical Association in October 2025. The multi-center, randomized controlled trial found participants using the t:slim X2 insulin pump with Control-IQ technology experienced http://www.streetinsider.com/FDA/Tandem+Diabetes+expands+CE+mark+approval+for+insulin+delivery+systems/26608658.html Fri, 05 Jun 2026 08:30:20 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Press+Releases/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html <p> SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced receipt of CE mark for expanded indications of its automated insulin delivery (AID) systems in Europe. The t:slim X2 and Tandem Mobi insulin delivery systems running Control-IQ+ AID technology are now approved for use by people with type 1 diabetes during pregnancy and adults with type 2 diabetes. </p><p> “These expanded indications underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide,” said John Sheridan, president and chief executive officer. “By expanding http://www.streetinsider.com/Business+Wire/Tandem+Diabetes+Care+Automated+Insulin+Delivery+Systems+Receive+CE+Mark+for+Type+2+Diabetes+and+Type+1+Diabetes+During+Pregnancy/26608649.html Fri, 05 Jun 2026 08:30:00 -0400 A.20822773 O.06012263 O.20370956 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+Jun+02++Filed+by%3A+Gasser+Elizabeth+Anne/26605712.html si-local-file:///var/storage/secattach/20260604/26605712.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+Jun+02++Filed+by%3A+Gasser+Elizabeth+Anne/26605712.html Thu, 04 Jun 2026 16:09:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+Jun+02++Filed+by%3A+Gasser+Elizabeth+Anne/26605712.html si-local-file:///var/storage/secattach/20260604/26605712.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+Jun+02++Filed+by%3A+Gasser+Elizabeth+Anne/26605712.html Thu, 04 Jun 2026 16:09:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Hansen+Shannon+Marie/26592014.html si-local-file:///var/storage/secattach/20260602/26592014.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Hansen+Shannon+Marie/26592014.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Hansen+Shannon+Marie/26592014.html si-local-file:///var/storage/secattach/20260602/26592014.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Hansen+Shannon+Marie/26592014.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Morrison+Susan/26592015.html si-local-file:///var/storage/secattach/20260602/26592015.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Morrison+Susan/26592015.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Morrison+Susan/26592015.html si-local-file:///var/storage/secattach/20260602/26592015.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Morrison+Susan/26592015.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Carpenter+Rick/26592018.html si-local-file:///var/storage/secattach/20260602/26592018.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Carpenter+Rick/26592018.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Carpenter+Rick/26592018.html si-local-file:///var/storage/secattach/20260602/26592018.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Carpenter+Rick/26592018.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Kyrillos+Jean-Claude/26592023.html si-local-file:///var/storage/secattach/20260602/26592023.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Kyrillos+Jean-Claude/26592023.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Kyrillos+Jean-Claude/26592023.html si-local-file:///var/storage/secattach/20260602/26592023.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Kyrillos+Jean-Claude/26592023.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Gasser+Elizabeth+Anne/26592025.html si-local-file:///var/storage/secattach/20260602/26592025.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++TANDEM+DIABETES+CARE++++++For%3A+May+29++Filed+by%3A+Gasser+Elizabeth+Anne/26592025.html Tue, 02 Jun 2026 16:21:00 -0400 O.06012263 TNDM